Sfoglia per Autore
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial
2020 Attarbaschi, A; Mann, G; Zimmermann, M; Bader, P; Barisone, E; Basso, G; Biondi, A; Cario, G; Cazzaniga, G; Colombini, A; Flotho, C; Kuhlen, M; Lang, P; Lauten, M; Linderkamp, C; Locatelli, F; Lo Nigro, L; Moricke, A; Niggli, F; Panzer-Grumayer, R; Parasole, R; Peters, C; Caterina Putti, M; Rizzari, C; Suttorp, M; Valsecchi, M; Conter, V; Schrappe, M
Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia
2019 Hijiya, N; Maschan, A; Rizzari, C; Shimada, H; Dufour, C; Goto, H; Kang, H; Guinipero, T; Karakas, Z; Bautista, F; Ducassou, S; Yoo, K; Zwaan, C; Millot, F; Aimone, P; Allepuz, A; Quenet, S; Hourcade-Potelleret, F; Hertle, S; Sosothikul, D
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia
2019 Fazio, G; Massa, V; Grioni, A; Bystry, V; Rigamonti, S; Saitta, C; Galbiati, M; Rizzari, C; Consarino, C; Biondi, A; Selicorni, A; Cazzaniga, G
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
2019 Portale, F; Cricrì, G; Bresolin, S; Lupi, M; Gaspari, S; Silvestri, D; Russo, B; Marino, N; Ubezio, P; Pagni, F; Vergani, P; Te Kronnie, G; Valsecchi, M; Locatelli, F; Rizzari, C; Biondi, A; Dander, E; D'Amico, G
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series
2019 Peri, A; Verna, M; Biffi, S; Alagna, L; Longhi, B; Migliorino, G; Foresti, S; Bandera, A; Rovelli, A; Rizzari, C; Gori, A; Colombini, A
Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children with Acute Lymphoblastic Leukemia: Results of a Retrospective Survey
2019 Giordano, P; Grassi, M; Saracco, P; Luciani, M; Colombini, A; Testi, A; Micalizzi, C; Petruzziello, F; Putti, M; Casale, F; Consarino, C; Mura, R; Mastrodicasa, E; Notarangelo, L; Onofrillo, D; Pollio, B; Rizzari, C; Tafuri, S; De Leonardis, F; Corallo, P; Santoro, N
Nationwide central diagnosis review for childhood solid tumors: From concept to realization of an Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) integrated project
2019 Spreafico, F; Quarello, P; Alaggio, R; Collini, P; Haupt, R; Mastronuzzi, A; Prete, A; Rabusin, M; Rizzari, C; Schumacher, F; Zecca, M; Pession, A; Fagioli, F
Acute myeloid leukaemia niche regulates response to L-asparaginase
2019 Michelozzi, I; Granata, V; DE PONTI, G; Alberti, G; Tomasoni, C; Antolini, L; GAMBACORTI PASSERINI, C; Gentner, B; Dazzi, F; Biondi, A; Coliva, T; Rizzari, C; Pievani, A; Serafini, M
Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children with Influenza
2019 Bautista, F; Engelhard, D; Rizzari, C; Baka, M; Saavedra-Lozano, J; Lopez-Medina, E; Nasmyth-Miller, C; Hernandez-Sanchez, J; Sturm, S
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study
2019 Testi, A; Attarbaschi, A; Valsecchi, M; Moricke, A; Cario, G; Niggli, F; Silvestri, D; Bader, P; Kuhlen, M; Parasole, R; Putti, M; Lang, P; Flotho, C; Mann, G; Rizzari, C; Barisone, E; Locatelli, F; Linderkamp, C; Lauten, M; Suttorp, M; Zimmermann, M; Basso, G; Biondi, A; Conter, V; Schrappe, M
Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature
2019 Dell'Acqua, F; Saettini, F; Castelli, I; Badolato, R; Notarangelo, L; Rizzari, C
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
2019 Rizzari, C; Lanvers-Kaminsky, C; Valsecchi, M; Ballerini, A; Matteo, C; Gerss, J; Wuerthwein, G; Silvestri, D; Colombini, A; Conter, V; Biondi, A; Schrappe, M; Moericke, A; Zimmermann, M; Von Stackelberg, A; Linderkamp, C; Frühwald, M; Legien, S; Attarbaschi, A; Reismüller, B; Kasper, D; Smisek, P; Stary, J; Vinti, L; Barisone, E; Parasole, R; Micalizzi, C; Zucchetti, M; Boos, J
A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia
2019 Zwaan, C; Söderhäll, S; Brethon, B; Luciani, M; Rizzari, C; Stam, R; Besse, E; Dutreix, C; Fagioli, F; Ho, P; Dufour, C; Pieters, R
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency
2018 Saettini, F; Moratto, D; Grioni, A; Maitz, S; Iascone, M; Rizzari, C; Pavan, F; Spinelli, M; Bettini, L; Biondi, A; Badolato, R
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia
2018 Zampini, M; Bisio, V; Leszl, A; Putti, M; Menna, G; Rizzari, C; Pession, A; Locatelli, F; Basso, G; Tregnago, C; Pigazzi, M
Therapeutic drug monitoring of asparaginase activity - Method comparison of MAAT and AHA test used in the international AIEOP-BFM ALL 2009 trial
2018 Lanvers-Kaminsky, C; Ruffer, A; Wurthwein, G; Gerss, J; Zucchetti, M; Ballerini, A; Attarbaschi, A; Smisek, P; Nath, C; Lee, S; Elitzur, S; Zimmermann, M; Moricke, A; Schrappe, M; Rizzari, C; Boos, J
Inotuzumab ozogamicin in older patients with acute lymphoblastic leukaemia: premises and promises
2018 Rizzari, C
Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
2018 Parasole, R; Valsecchi, M; Silvestri, D; Locatelli, F; Barisone, E; Petruzziello, F; Putti, M; Micalizzi, C; Colombini, A; Mura, R; Mina, T; Testi, A; Notarangelo, L; Santoro, N; Casini, T; Consarino, C; Nigro, L; Ziino, O; Giagnuolo, G; Rizzari, C; Conter, V
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000)
2018 Schrappe, M; Bleckmann, K; Zimmermann, M; Biondi, A; Möricke, A; Locatelli, F; Cario, G; Rizzari, C; Attarbaschi, A; Valsecchi, M; Bartram, C; Barisone, E; Niggli, F; Niemeyer, C; Testi, A; Mann, G; Ziino, O; Schäfer, B; Panzer-Grümayer, R; Beier, R; Parasole, R; Göhring, G; Ludwig, W; Casale, F; Schlegel, P; Basso, G; Conter, V
Acute myeloid leukemia in Baraitser–Winter cerebrofrontofacial syndrome
2017 Cianci, P; Fazio, G; Casagranda, S; Spinelli, M; Rizzari, C; Cazzaniga, G; Selicorni, A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile